July 25, 2023

The National Stock Exchange of India Limited

The BSE Limited

Exchange Plaza, Bandra-Kurla Complex,

Phiroze Jeejeebhoy Towers,

Bandra (E), Mumbai - 400 051.

Dalal Street, Mumbai - 400 001.

Scrip Code: STAR

Scrip Code: 532531

Dear Sirs,

Re: Announcement of Board Meeting under Regulation 29 of SEBI Listing Regulations

This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, August 2, 2023, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2023, amongst other matters.

Further, as per provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company.

This is for your kind information and record purposes.

Thanks & Regards,

For Strides Pharma Science Limited,

MANJULA RAMAMURTHY

Digitally signed by

MANJULA RAMAMURTHY Date: 2023.07.25 18:30:35 +05'30'

Manjula Ramamurthy

Company Secretary

ICSI Membership No.: A30515

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Strides Pharma Science Ltd. published this content on 26 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 July 2023 06:38:06 UTC.